Search: 15AM Faculty
Results 1 - 9 of 9

Kirsten Parr

Global Head of CMC Connect, Client Services
CMC Connect

Type of Company:
Communications Agency
Professional Degrees: CMPP
CMPP Certified: 03/2014

Bio: Kirsten has more than 20 years' experience in medical publications and communications and worked for several different agencies before joining CMC in 2005. She moved to her current position as Head of Client Services in 2014. Kirsten has partnered with clients in the medical publications arena throughout her career supporting a broad range of therapy areas and covering the full product lifecycle. She has led teams responsible for developing publications strategies; managing publication plans and delivering all types of publications from abstracts and posters through to manuscripts and reviews. Her experience covers both global and regional publications. As Head of Client Services, she plays a role in ensuring that CMC build publications teams that are not only skilled at writing but knowledgeable and committed to delivering work that is ethical and of a high standard and quality. She is an active and enthusiastic member of ISMPP and regularly attends both the Global and European annual meetings. She is CMPP accredited and currently volunteering on the Programme and Abstract Committees for the 2017 Annual Meeting.

Daniel Pascheles

CEO
Molekule Consulting

Type of Company:
Other
Professional Degrees: PhD

Bio: Dr. Pascheles joined Molekule Consulting in early 2017 as Chief Executive Officer and has over 20 years of experience in building world-class global competitive intelligence. As manager of large CI teams, Daniel oversaw and led during his successful career in the biopharmaceutical industry hundreds of primary CI projects, competitive simulations and strategic planning sessions. Prior to joining Molekule Consulting, Dr. Pascheles was Vice President and Head of Global Competitive Intelligence at Merck & Co /MSD for the last 12 years. Before that he worked for Aventis and its predecessor company (Hoechst Marion Roussel, Marion Merrell Dow) for 14 years in various positions such as Global Head of CI, European Head of Sales and Marketing Administration, European Head of Strategic Planning and General Manager Switzerland. Dr. Pascheles studied Pharmacy at the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland. He received his Ph.D. in Pharmaceutical Technology from the same university. He did additional studies at the University of Kansas in Lawrence, Kansas. Daniel is Past-President and a current Board member of the Pharmaceutical Business Intelligence & Research Group (PBIRG). He is also a member of the Society of Competitive Intelligence Professionals (SCIP) and the Licensing Executive Society (LES). He is a well-known speaker/chairman of International Conferences on Competitive Intelligence. He is a member of the Editorial Advisory Board member of the Pharmaceutical Executive magazine and publishes regularly in various trade magazines. Daniel is also Visiting Professor at the Rey Juan Carlos University in Madrid teaching a Master Class in CI.

Patti Peeples

CEO and Founder, CEO and Founder
HealthEconomics.Com

Type of Company:
Creative Service Provider
Professional Degrees: PharmD, PhD

Bio: Dr. Patti Peeples is a health economist, educator, pharmacist, and entrepreneur with 30 years of experience in healthcare economics. She is the Founder and CEO of HealthEconomics.Com, the global CONNECTED COMMUNITY for the health economics and outcomes research (HEOR) community. She is also Principal Researcher at HE Institute, a value communications group. Dr. Peeples has served in senior positions in Medical Affairs, Health Outcomes, and Product Management with ALZA, Novartis, and Xcenda. Patti serves on multiple journal Editorial Boards, including the Journal of Managed Care & Specialty Pharmacy, and the Journal of Clinical Pathways. She devotes her time to several Boards of Directors, including the American Foundation for Pharmaceutical Education (AFPE) and Yoga 4 Change. Peeples has authored more than 50 peer-reviewed publications on cost-effectiveness of healthcare interventions. She holds a PhD in Health Economics from the University of the Sciences in Philadelphia, an M.S. in Pharmaceutical Marketing, and a B.S. in Pharmacy and she completed an administrative Pharmacy Residency program.

Jeffrey Pfister

Director Publication Practices and Standards, Global Scientific and Medical Publications
Merck

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP, MBA
CMPP Certified: (9/2011)

Bio: Jeff Pfister has over 30 years of pharmaceutical industry experience, much of it in scientific communications and compliance. Jeff is currently the publication standards and practices lead at Merck & Co., Inc. managing publication compliance. Jeff earned a BBA from The University of Texas at Austin, a BS from Texas A & M University-Corpus Christi and an MBA from the University of North Florida-Jacksonville.

Claudia Piano

SVP/Director, Client Engagement
CMC Connect

Type of Company:
Communications Agency
Professional Degrees: BA/BS, CMPP, MA
CMPP Certified: (9/2012)

Bio: Claudia Piano is currently SVP/Director, Client Engagement for CMC Connect. Claudia has over 25 years' experience at leading healthcare communications agencies, including over 9 years with CMC. Since joining CMC, Claudia led the growth of the US-based team for CMC overall, then led a fully integrated US/UK client service team for the Affinity division, and now leads BD growth efforts for the Connect division. CMC Connect works with several pharma company clients, providing publication planning and delivery as well as strategic medical communication services, across a wide range of therapy areas. Prior to joining CMC, Claudia worked her way through the ranks of agency life in client services, providing account leadership, strategic guidance, and tactical expertise to both global and US domestic clients. Claudia has a Masters of Liberal Arts from Harvard University, is a Certified Medical Publication Professional (CMPP) and has contributed to several ISMPP committees over the years, currently serving on the Nominating and Program Committees. She has also participated as a faculty member and co-authored posters presented at the ISMPP Annual Meeting.

Michael Platt

Managing Director
Virgo Health

Type of Company:
Communications Agency
Professional Degrees: BA/BS, MS
CMPP Certified: (9/2010)

Bio: Michael has over 24 years of industry experience and a broad knowledge of the pharmaceutical, biotechnological, medical device, and healthcare fields. His expertise spans prelaunch, launch, and postlaunch initiatives including publication planning, advisory boards, sales training, MSL training, digital engagement, and regulatory writing. In addition, Michael worked for 10+ years in continuing education where he issued credentials and certifications to physicians, nurses, and pharmacists, as well as publication professionals. Some of his therapeutic areas of focus include biologics, oncology, hematology, rare diseases, cardiology, allergy and asthma, infectious disease, gastroenterology, urology, and rheumatology. Michael manages a team of professionals who develop compelling, yet compliant, medical communications. The team at Virgo Health focuses on strategic consulting for medical affairs and scientific communication initiatives. Other offerings from Virgo Health include advisory board and steering committee meetings with medical information and clinical advisors, thought leader identification and development, market surveillance, and full-scale publication planning. Michael currently provides strategic consulting for peer-to-peer initiatives on the cardio-protective benefits of Jardiance in patients with type 2 diabetes who have had a previous cardiovascular event. Michael also worked on the Door-to-Needle initiative funded by Genentech, as well as the Genentech product Retavase. To bring attention to the finding that earlier treatment for MI improved outcomes for patients, his team developed a program that, when implemented, reduced treatment times for suspected heart attack victims, which improved patient outcomes. Another physician-based program that immediately improved patient outcomes addressed a rare disease, infantile spasms or West syndrome, and was supported by Questcor. Many pediatric neurologists were treating the symptoms of this cognitively detrimental disease, but they were not completing a second test to insure that the resulting hypsarrhythmia was resolved in the infant. Michael¿s team developed a series of educational programs that increased awareness and action on the part of these physicians. Michael came to Virgo Health from MedVal, where as President, EVP, he led a writing and editorial team focused on publication planning and publications, as well as regulatory writing and medical affairs initiatives. Previously, he was CEO of Fission Communications, a New York-based medical education and communications company he founded in 2001, where he guided the development and execution of distinctive medical communications programs. He was also Director of Business Development at Ventiv Health Communications in Stamford, Connecticut, and has held positions at Genecom, LLC, and Q.E.D. International, Inc. Michael began his career in the research sector of the pharmaceutical industry as a project technician at OSI Pharmaceuticals, a drug discovery company based in New York. Michael is the past chair of the CMPP Board, the certification body of the International Society of Medical Publication Professionals (ISMPP). He is also an active member of the ISMPP U Committee. As a past chair of ISMPP U, Michael assisted in establishing needs-based sessions for ISMPP U that met educational gaps for publication professionals.

Larry Radican

Vice President, HEOR - Value Evidence Generation
Peloton Advantage

Type of Company:
Communications Agency
Professional Degrees: MPH, PhD

Bio: Larry Radican, PhD, MPH, Vice President, Health Economics and Outcomes Research (HEOR) Value Evidence Generation, is responsible for overseeing Peloton Advantage's HEOR capabilities and ensuring delivery of high-quality HEOR evidence-generation strategies and solutions to clients. He has more than 25 years of academic and industry experience in HEOR, health technology assessment, evidence-based medicine, real-world data (RWD), comparative effectiveness research, and population health. Prior to joining Peloton Advantage, Dr. Radican held multiple positions over a 22-year span at Merck & Co.s Center for Observational and Real-world Evidence where he was responsible for obtaining US customer insights to support RWD study planning; leading US and global HEOR studies and value evidence generation strategic planning for dozens of inline and developmental products in numerous therapeutic area; and managing long-term academic-industry research partnerships. Prior to Merck, Dr. Radican worked at Emron Inc., where he designed HEOR studies and at Dover General Hospital and Medical Center in New Jersey, where he assessed local and regional health needs and led communications initiatives that promoted hospital services, educational seminars, and screening programs to the local community. He has published more than 60 articles on outcomes research and real-world evidence in peer-reviewed journals and has authored and/or presented more than 60 abstracts at scientific conferences. Dr. Radican received his PhD in Epidemiology and his MPH in Health Care Administration and Organization from Rutgers University School of Public Health, and his BA in Economics from Colby College. He also currently serves as an Assistant Adjunct Professor at Rutgers University School of Public Health.

Tom Rees

Communications Director
Oxford PharmaGenesis

Type of Company:
Communications Agency
Professional Degrees: BA/BS, MS, PhD
CMPP Certified: 3/2015

Bio: Tom has over 20 years' experience in medical communications and publications planning, and is currently a Communications Director at Oxford PharmaGenesis, having previously held roles in strategic consultancy, as a team leader and lead medical writer. Tom is a regular contributor to the US and European ISMPP meetings, and has delivered a number of workshops and new research presentations on the topics of publications innovations, good publications practice, and patient communications, publication metrics (including altmetrics), and social media. He currently serves on the ISMPP Social Media/Web-based Metrics Working Group and is a past member of the ISMPP Credentialing and Global Workshop Committees. Tom holds a PhD in Biotechnology from Cranfield University in the UK, and is CMPP certified.

Steven Rizk

Group Leader, Healthcare Communications
Genentech

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP, JD, PharmD
CMPP Certified: (9/2015)

Bio: Steve Rizk is a Group Leader, Healthcare Communications in Global Product Development Medical Affairs at Roche. Steve serves as the Roche Global Process Owner of the Scientific Credibility Policy and has oversight of the Global Publication Publication Policy and Processes. He also serves as a core member of the Roche Data Sharing Leadership Committee. In his roles, he has overseen policy and process updates and recently has driven the evolution of standards and processes required to support the development of clinical trial plain language results summaries necessary to meet upcoming regulatory requirements. Steve has more than 20 years of healthcare experience in the biopharmaceutical industry, hospital pharmacy, and retail settings. In the biopharmaceutical industry, he has performed roles in scientific communications, global publications, field medical science, clinical study management and clinical science at Roche and at Bristol-Myers Squibb Company. Steve received Bachelor's and Doctorate Degrees in Pharmacy from the Ernest Mario School of Pharmacy at Rutgers University in New Jersey. He also earned a Juris Doctor Degree from Fordham University School of Law in New York City and is an ISMPP Certified Medical Publication Professional.